Please use this identifier to cite or link to this item: https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/115
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCipriani, Andrea
dc.contributor.authorCowen, Philip J
dc.date.accessioned2018-10-23T11:48:02Z
dc.date.available2018-10-23T11:48:02Z
dc.date.issued2018-06
dc.identifier.citationCipriani, Andrea and Cowen, Philip J. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel. Lancet Psychiatry 2018-06-01, Volume 5, Issue 6, Pages 453-455en
dc.identifier.issn2215-0374
dc.identifier.urihttps://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/115
dc.descriptionPublished online at: https://doi.org/10.1016/S2215-0366(18)30170-6 Eligible users can access the full text via NHS OpenAthens at [https://www.clinicalkey.com/#!/content/journal/1-s2.0-S2215036618301706] (login required).en
dc.description.abstractComment: This current study describes the therapeutic use of MDMA by committed experts in a specialised setting in a small group of participants, most of whom self-referred for the trial. The unmet need for better PTSD treatment, particularly in veterans and first responders, is undoubted. However, the generalisability of the benefit of MDMA-assisted psychotherapy to more mainstream psychiatry remains to be established, recalling perhaps the famous American watchword, “Will it play in Peoria?”en
dc.language.isoenen
dc.subjectVeteransen
dc.subjectPost-Traumatic Stress Disorder (PTSD)en
dc.subjectFirst Responders
dc.title3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnelen
dc.typeArticleen
Appears in Collections:Anxiety Disorders

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.